Advances in the immunopathology of HIV infection;Avances en la inmunopatología de la infección por el VIH

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 8, 2004, Pages 486-496

  Alcamí, José ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Immune patogenesis; Immune response; Viral escape mechanisms

Indexed keywords

CD4 ANTIGEN; MESSENGER RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOPATHOGENIC EFFECT; DISEASE COURSE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFECTION; LIFE CYCLE; LYMPHOCYTOPENIA; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TARGET CELL DESTRUCTION; VIRUS GENE; VIRUS REPLICATION;

EID: 8644279618     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13066856     Document Type: Review

References (51)

1. Sotrel A, Dal Canto MC. HIV-1 and its causal relationship to immunosuppression and nervous system disease in AIDS: a review. Hum Pathol 2000;31:1274-98.
2. Stevenson M. HIV-1 pathogenesis. Nature Med 2003;7:853-60.
3. Greene WC, Peterlin BM. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nat Med 2002;8:673-80.
4. Van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003;3:697-709.
5. Geijtenbeek TB, Kwon DS, Torensma R, Van Vliet SJ, Van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587-97.
6. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48.
7. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu Rev Immunol 1999;17:657-700.
8. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998;280:1949-53.
9. Alcamí J, Laín de Lera T, Folgueira L, Pedraza MA, Jacque JM, Bachelerie F, et al. Absolute dependence on kB responsive elements for initiation and tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995;14:1552-60.
10. Bermejo M, Sánchez-Palomino S, Usán L, Alcamí J. Dynamics of HIV replication in lymphocytes and consequences in the efficacy of protease inhibitors. J Med Virol 2004;73:502-7.
11. Emerman M, Malim MH. HIV-1 regulatory/accesory genes: keys to unraveling viral and host cell biology. Science 1998;280:1880-4.
12. Von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, et al. The protein network of HIV budding. Cell 2003;114:701-13.
13. Cullen BR. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 1998;93:685-92.
14. Marin M, Rose KM, Kozak SL, Rabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003;9:1398-403.
15. Haase AT. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol 1999;17:625-56.
16. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274:985-9.
17. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.
18. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002;417:95-8.
19. McCune JM. The dynamics of CD4+ T cell depletion in HIV disease. Nature 2001;410:974-79.
20. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
21. Parker NG, Notermans DW, De Boer RJ, Roos MT, de Wolf F, Hill A, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998;4:208-14.
22. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001;410:980-7.
23. Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, Corey L, et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med 1999;5:34-41.
24. Alcami J. HIV and apoptosis: a complex interaction between cell death and virus survival. Viruses and Apoptosis. Alonso C (Ed.) Series: Progress in Molecular and Subcellular Biology. Life Sciences Editorial, 2004.
25. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med 1995;1:129-34.
26. Cloyd MW, Chen JJ, Adeqboyega P, Wang L. How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Curr Mol Med 2000;1:545-50.
27. Ferri KF, Jacotot E, Blanco J, Este JA, Zamzami N, Susin SA, et al. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med 2000;192:1081-92.
28. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, et al. The HTV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000;191:33-46.
29. Kim TA, Avraham HK, Koh YH, Jiang S, Park IW, Avraham S. HIV-1 tat-mediated apoptosis in human brain microvascular endothelial cells. J Immunol 2003;170:2629-37.
30. Ameisen JC. Apoptosis subversion: HIV-Nef provides both armor and sword. Nat Med 2001;7:1181-2.
31. Fry TJ, Mackall CL. What limits immune reconstitution in HIV infection? Divergent tools converge on thymic function. AIDS 2001;15:1881-2.
32. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000;1:285-9.
33. Bandrés JC, Zolla-Pazner S. Inmunidad humoral en la infección por el VIH. En: González J, Moreno S, Rubio R, editors. Infección por el VIH 1999. Madrid: Doyma, 1999.
34. Nabel GJ, Sullivan J. Antibodies and resistance to natural HIV infection. N Engl J Med 2000;343:17-9.
35. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000;6:207-10.
36. Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003:4144-9.
37. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002;420:678-82.
38. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al. Antibody neutralization and escape by HIV-1. Nature 2003;422:307-12.
39. Robinson HL, Montefiori DC, Johnson RP, Manson KH, Kalish ML, Lifson JD, et al. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med 1999;5:526-34.
40. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PF, Moore JP, et al. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004;5:233-6.
41. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000;407:523-6.
42. Richman D. The challenge of the immune control of HIV infection. J Clin Invest 1999;104:677-8.
43. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-11.
44. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-50.
45. Metzner KJ, Jin X, Lee FV, Gettie A, Bauer DE, Di Mascio M, et al. Effects of in vivo CD8+ T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Exp Med 2000;191:1921-31.
46. Kedzierska K, Crowe SM, Turville S, Cunningham AL. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 2003;13:39-56.
47. Agace WW, Amara A, Roberts AI, Pablos JL, Thelen S, Uguccioni M, et al. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol 2000;10:325-8.
48. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002;298:995-1000.
49. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, et al. HIV-specific CD8+ T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nat Immunol 2002;3:1061-8.
50. Wei X, Decker JM, Wang S, et al. Antibody neutralization and escape by HIV-1. Nature 2003;422:307-12.
51. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002;53:557-93.